iifl-logo-icon 1

Lupin Ltd Shareholding Pattern

1,905.35
(-3.65%)
Feb 21, 2025|03:31:14 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Lupin Ltd SHAREHOLDING

Dec-2024Sep-2024Jun-2024Mar-2024Dec-2023

Promoter

-

-

-

-

-

Foreign

0.28%

0.28%

0.28%

0.28%

0.28%

Indian

46.66%

46.67%

46.7%

46.72%

46.76%

Total Promoter

-

-

-

-

-

Institutions

46.78%

46.6%

46.1%

46.05%

45.84%

Non-Institutions

6.26%

6.43%

6.91%

6.93%

7.1%

Total Non-Promoter

53.04%

53.03%

53.01%

52.99%

52.95%

Custodian

0%

0%

0%

0%

0%

Total

100%

100%

100%

100%

100%

  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.28%

Foreign: 0.28%

Indian: 46.66%

Non-Promoter- 46.78%

Institutions: 46.78%

Non-Institutions: 6.26%

Custodian: 0.00%

Lupin: Related NEWS

Lupin Secures FDA Nod for First-to-File Generic HIV Drug
5 Feb 2025|09:27 AM

Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets are therapeutic equivalents of Symtuza Tablets 800 mg/150 mg/200 mg/10 mg brand of Janssen Products, LP.

Read More
Top Stocks for Today - 9th January 2025
9 Jan 2025|07:02 AM

Here are some of the stocks that may see significant price movement today: Tata Motors, BHEL, Hindalco, Lupin, etc.

Read More
Lupin Acquires Huminsulin Brand from Eli Lilly to Boost Diabetes Portfolio
31 Dec 2024|02:45 PM

Lupin was already selling Huminsulin under the license agreement entered with Lilly India.

Read More
Lupin gets USFDA approval for generic HIV tablets
19 Dec 2024|11:48 AM

The approval enables Lupin to offer a generic version of Descovy pills, which were originally produced by Gilead Sciences Inc.

Read More
Top Stocks for today - 16th December 2024
16 Dec 2024|07:20 AM

Here are some of the stocks that may see significant price movement today: Reliance Industries, Biocon, Bharat Forge, etc.

Read More
Lupin Q2 Profit Surges 74%, Revenue Up 12.6%
11 Nov 2024|10:20 AM

Lupin ranks as the third-largest pharmaceutical player in the U.S. by prescriptions and seventh in the Indian Pharmaceutical Market (IPM).

Read More
Lupin Q1 Net Profit Jumps 77%, Shares Rise 5%
7 Aug 2024|10:44 AM

Lupin Limited reports a 77% increase in Q1 net profit to ₹801.3 crores, with total sales up 16.3%.

Read More
Top 10 stocks for today – 7th August 2024
7 Aug 2024|08:16 AM

Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.

Read More
Top 10 stocks for today – 06th August 2024
6 Aug 2024|09:11 AM

Here are some of the stocks that may see significant price movement today: Adani Energy Solutions, Bharti Airtel, Bharti Hexacom, etc.

Read More
Lupin sells US women’s health business for $84 million
16 Jul 2024|11:15 AM

According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.